NK
Nilesh Kumar Dudhwewala
About Nilesh Kumar Dudhwewala
Data last updated:
Nilesh Kumar Dudhwewala is a Managing Director at Salud Care (India) Limited (since 2012), Whole-Time Director at Alvio Pharmaceuticals Private Limited (since 2015) and Designated Partner at Uncap Skincare Llp (since 2026). The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹118 Cr; the largest is Salud Care (India) Limited at ₹80.41 Cr (FY 2025). Earlier, Nilesh Kumar Dudhwewala was a Director at Cubitex Marketing Pvt Ltd (2003–2008) and Director at Esmero Research Private Limited (2014–2020) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 31 Jul 2012 | 2003 | ₹80.41 Cr (FY 2025) | Active | |
| Whole-Time Director | 07 Oct 2015 | 2008 | ₹37.10 Cr (FY 2025) | Active | |
| Designated Partner | 14 Aug 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Aug 2003 | 1994 | ₹86.3 Lakh (FY 2022) | Active | |
| Director | 05 Dec 2014 | 2014 | ₹21.30 Cr (FY 2024) | Active | |
| Designated Partner | 23 Jan 2019 | 2019 | ₹3.33 Cr (FY 2025) | Active | |
| Director | 23 Jul 2009 | 2008 | ₹6.9 Lakh (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nilesh Kumar Dudhwewala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dewang Madhukar Modi | 00328931 | Salud Care (India) Limited | Director |
| Manish Kumar Dudhwewala | 00674856 | Salud Care (India) Limited , Alvio Pharmaceuticals Private Limited and 1 more | Director |
| Nidhi Devesh Bhatt | Salud Care (India) Limited | Company Secretary | |
| Sanket Singhania | 10592493 | Salud Care (India) Limited | Director |
| Vishal Pramodray Godadesai | Salud Care (India) Limited | Cfo | |
| Vishrut Chandramauli Pathak | 03278445 | Salud Care (India) Limited | Director |
| Chandrasingh Shivrambhai Purohit | 00199651 | Uncap Skincare Llp | Partner |
| Sheetal Dudhwewala | 11893600 | Uncap Skincare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilesh Kumar Dudhwewala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilesh Kumar Dudhwewala
Nilesh Kumar Dudhwewala currently holds 3 directorships: Salud Care (India) Limited (Managing Director, since 31 Jul 2012, revenue ₹80.41 Cr (FY 2025)); Alvio Pharmaceuticals Private Limited (Whole-Time Director, since 07 Oct 2015, revenue ₹37.10 Cr (FY 2025)); Uncap Skincare Llp (Designated Partner, since 14 Aug 2026).
Nilesh Kumar Dudhwewala was first appointed on 23 Aug 2003 as Director at Cubitex Marketing Pvt Ltd. The most recent appointment on record is 14 Aug 2026 at Uncap Skincare Llp.
The 2 current companies of Nilesh Kumar Dudhwewala that report revenue have a combined latest revenue of ₹118 Cr: Salud Care (India) Limited ₹80.41 Cr (FY 2025); Alvio Pharmaceuticals Private Limited ₹37.10 Cr (FY 2025).
Nilesh Kumar Dudhwewala held 4 earlier board appointments: Cubitex Marketing Pvt Ltd (Director, 23 Aug 2003 to 27 Sep 2008); Esmero Research Private Limited (Director, 05 Dec 2014 to 20 Jan 2020); Stelvio Healthcare Llp (Designated Partner, 23 Jan 2019 to 29 Nov 2021); Salud Health Care Private Limited (Director, from 23 Jul 2009).
The current boards of Nilesh Kumar Dudhwewala's companies include Dewang Madhukar Modi (Salud Care (India) Limited), Manish Kumar Dudhwewala (Salud Care (India) Limited), Nidhi Devesh Bhatt (Salud Care (India) Limited), Sanket Singhania (Salud Care (India) Limited), Vishal Pramodray Godadesai (Salud Care (India) Limited), Vishrut Chandramauli Pathak (Salud Care (India) Limited), among others.